The gravity of the threat posed by vivax malaria to public health has been poorly
appreciated. The widely held misperception of Plasmodium vivax as being relatively …

Currently, migrants and other mobile individuals, such as migrant workers and asylum
seekers, are an expanding global population of growing social, demographic and political …

Malaria is caused by infection with protozoan parasites of the Plasmodium genus,
transmitted to humans by female anopheline mosquitoes. Plasmodia have adapted to a …

Plasmodium vivax infects 130–435 million of the 2.6 billion people living at risk of infection.
Recent studies suggest that vivax malaria can become lethal in a similar way to severe …

Malaria in sub-Saharan Africa has historically been almost exclusively attributed to
Plasmodium falciparum (Pf). Current diagnostic and surveillance systems in much of sub …

ContextMany US clinicians and laboratory personnel are unfamiliar with the diagnosis and
treatment of malaria. ObjectivesTo examine the evidence base for management of …

Resistance to Plasmodium vivax blood-stage infection has been widely recognised to result
from absence of the Duffy (Fy) blood group from the surface of red blood cells (RBCs) in …

Malaria is the most devastating parasitic infection in the world, annually causing over 1
million deaths and extensive morbidity. The global burden of malaria has increased over the …

Plasmodium vivax is considered to be absent from Central and West Africa because of the
protective effect of Duffy negativity. However, there are reports of persons returning from …

Background Artemisinin combination therapy (ACT) is recommended as first-line treatment
for uncomplicated Plasmodium falciparum malaria, whereas chloroquine is still commonly …